<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02171364</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0536</org_study_id>
    <nct_id>NCT02171364</nct_id>
  </id_info>
  <brief_title>Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Prospective Randomized Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiofrequency catheter ablation is highly effective in the treatment of patients with
      persistent atrial fibrillation. In order to decrease the recurrence rate after catheter
      ablation, the investigators propose to apply 'virtual' ablation on patient-specific atria by
      simulating 3D atrial computer model. The investigators will test with five different set of
      ablation methods and find successful methods for a specific patient. Then, this result will
      be compared to empirical catheter ablation result by randomly controlled trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">September 1, 2015</completion_date>
  <primary_completion_date type="Actual">September 1, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of hospitalization rate</measure>
    <time_frame>1, 3, 6, 12, 18 and 24 months after catheter ablation and every 6 months thereafter.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurence of cardiovascular disease</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence of AF</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>virtual simulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This intervention group is to choose the best effective method operation to patients by simulating 3D atrial computer model which consider patient's heart size and shape.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The other intervention group is to operate the atrial fibrillation by physician's personal experience, not by virtual simulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Virtual ablation in based 3D CT of patient who diagnosed AF</intervention_name>
    <arm_group_label>virtual simulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional ablation based on physician's personal experience</intervention_name>
    <arm_group_label>conventional ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to
             uncontrolled pulse rate by anti-arrhythmic drug therapy.

        Exclusion Criteria:

          -  AF patients who have severe heart deformations or blood problems.

          -  The patients who had been performed catheter ablation of atrial ablation.

          -  The patients who missed out to recording of 3D CT, echo and electrocardiography.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2014</study_first_posted>
  <last_update_submitted>March 15, 2019</last_update_submitted>
  <last_update_submitted_qc>March 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

